Qiying Liu

ORCID: 0000-0002-5364-1595 · 2 papers in corpus
review 2025
Frontiers in immunology ·doi:10.3389/fimmu.2025.1578723

Ovarian cancer(OC) is the second most common gynecological malignancy worldwide. While traditional treatments such as cytoreductive surgery, chemotherapy, and targeted drugs have made progress, patients with advanced disease still face high…

lab-animal 2020
Acta histochemica ·doi:10.1016/j.acthis.2020.151600

OBJECTIVES: Aim of this study is to explore whether quercetin can inhibit the enlarged fibrogenic responses of endometrial stromal cells by increasing the level of microRNA-145 (miR-145) and mediating the TGFβ1/Smad2/Smad3 signaling pathway…